Most Recent
Two proponents of Bitcoin Cash have battled before IP Australia over the trade mark 'Bitcoin Cash City', with one claiming he coined it in a text message in 2019.
US biotech company Regeneron Pharmaceuticals has sued Sandoz, claiming it is threatening to infringe the patent for its Eylea biologic, used to treat macular degeneration and diabetic macular oedema.
Green iron start-up Element Zero has said it will fight Fortescue’s bid to access nearly nine million documents collected under a controversial search order in the mining giant’s case alleging former employees misappropriated its process for carbon dioxide-free iron.
US lab products giant Beckman Coulter has successfully opposed an Australian biotech's bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman's ‘CytoFLEX’ mark.
Green iron start-up Element Zero has lost its latest bid to set aside search orders in a case by Fortescue alleging former employees misappropriated its process for carbon dioxide-free iron.
The High Court won't hear Bayer's appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company's claim the decision has "profound" consequences for drug R&D.
BHP and mining equipment company Epiroc Australia have resolved a lawsuit by Rio Tinto subsidiary Technological Resources over a patent for an autonomous drilling system.
Element Zero has denied claims that three former Fortescue employees, including one executive, misused confidential information and developed a green iron process on the company dime.
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
AI tech company Paige can't patent a tool to provide quality control for analysis of pathology images, with IP Australia finding the invention is merely an “administrative scheme” to automate the role of human pathologists.